Alessandro Armuzzi

Professor Alessandro Armuzzi is a Full Professor at Humanitas University and Head of the Gastroenterology Department at Humanitas Research Hospital in Rozzano, Milan. He serves as Director of the Postgraduate Residency Program for Digestive System Diseases and leads the School of Specialization in Digestive System Diseases. His research focuses on inflammatory bowel diseases (IBD), particularly ulcerative colitis and Crohn’s disease, with an emphasis on biological therapies, patient-reported outcomes, and disease management strategies. He has contributed extensively to studies on treatment efficacy, drug safety (e.g., tofacitinib, golimumab, vedolizumab), and clinical decision-making in IBD. Professor Armuzzi also leads initiatives in transition care for pediatric-to-adult IBD patients and explores the interplay between IBD and comorbidities like colorectal cancer. His work integrates clinical, translational, and epidemiological approaches to improve patient care and outcomes.

He is affiliated with multiple Humanitas Group hospitals, emphasizing a strong clinical-research nexus. His leadership roles include directing residency programs and contributing to international guidelines (e.g., ECCO guidelines on IBD therapeutics). His research often addresses real-world challenges in IBD management, such as biosimilar utilization and the impact of therapies on quality of life.